MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1

Matricellular proteins and survival in patients with pancreatic cancer: A systematic review

(2018) Sirio Fiorino et al.   PANCREATOLOGY

MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1

(2018) Yaming Li et al.   Cell Death & Disease

Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR

(2017) Luiza Handschuh et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Droplet digital PCR for quantification of ITGA6 in a stool mRNA assay for the detection of colorectal cancers

(2017) Elizabeth Herring et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma

(2017) Shu-De Feng et al.   OncoTargets and Therapy

Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma

(2017) Xiaobo Bo et al.   Oncotarget

Low plasma levels of miR-101 are associated with tumor progression in gastric cancer

(2017) Taisuke Imamura et al.   Oncotarget

Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action

(2017) Xia Yang et al.   FEBS Open Bio

miRNA-101 Suppresses Epithelial-to-mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells

(2016) Wenli Jiang et al.   Anti-Cancer Agents in Medicinal Chemistry

MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer

(2016) HAITAO GUAN et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Pancreatic cancer

(2016) Terumi Kamisawa et al.   LANCET

Methyl jasmonate induces the apoptosis of human colorectal cancer cells via downregulation of EZH2 expression by microRNA-101

(2016) Zheng Peng et al.   Molecular Medicine Reports

MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS

(2016) Yongqi Long et al.   Molecular Medicine Reports

miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1

(2016) Wei Lu et al.   Oncotarget

MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C

(2015) GANG DENG et al.   Molecular Medicine Reports

Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction

(2015) JIAN CHEN et al.   ONCOLOGY REPORTS

Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma

(2015) Jian Li et al.   PATHOLOGY & ONCOLOGY RESEARCH

Novel Targets in Pancreatic Cancer Research

(2015) Geoffrey Kozak et al.   SEMINARS IN ONCOLOGY

MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges

(2015) Huiyin Lan et al.   Biomed Research International

Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer

(2014) X.-L. Lai et al.   Clinical & Translational Oncology

Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway

(2014) QIANG BU et al.   Molecular Medicine Reports

MicroRNA gene polymorphisms in pancreatic cancer

(2013) Emmanouel Pavlakis et al.   PANCREATOLOGY